TFX
HealthcareTeleflex Incorporated
$124.46
+$2.06 (+1.68%)
Jan 5, 2026
Price History (1Y)
Analysis
Teleflex Incorporated is a healthcare company operating in the medical instruments and supplies industry. With a market capitalization of $5.50 billion, it is a significant player in its sector. The company has a substantial workforce of 14,100 employees. From a financial health perspective, Teleflex Incorporated has reported mixed results. Its gross margin stands at 54.0%, while the operating margin is 12.4%. However, the net income (TTM) is negative at -$327.9 million. The company's returns on equity and assets are -7.9% and 4.9%, respectively. Teleflex Incorporated has a significant amount of debt, totaling $2.89 billion, but also holds cash reserves of $377.20 million. In terms of valuation context, the forward P/E ratio is 8.19, indicating a relatively low price-to-earnings multiple. The revenue growth rate (YoY) stands at 19.4%, which may suggest some level of momentum in the company's financial performance. Teleflex Incorporated also offers a dividend yield of 111.0%, although this is likely due to the negative net income rather than an attractive payout ratio of 31.7%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Visit website →Key Statistics
- Market Cap
- $5.50B
- P/E Ratio
- N/A
- 52-Week High
- $185.94
- 52-Week Low
- $102.58
- Avg Volume
- 630.31K
- Beta
- 0.93
- Dividend Yield
- 111.00%
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NYQ
- Country
- United States
- Employees
- 14,100